Parhelia Biosciences | Undisclosed Amount | (Oct 18, 2023)
Cloover | $7,388,000 | (Oct 18, 2023)
Hallmark Health Care Solutions | Undisclosed Amount | (Oct 18, 2023)
OurCrowd
Israel
- Jerusalem
- 05/12/2022
- Series B
- $43,200,000
OurCrowd is a global venture investing platform that empowers institutions and individuals to invest and engage in emerging companies. The most active venture investor in Israel, OurCrowd vets and selects companies, invests its capital, and provides its global network with unparalleled access to co-invest and contribute connections, talent and deal flow. OurCrowd builds value for its portfolio companies throughout their lifecycles, providing mentorship, recruiting industry advisors, navigating follow-on rounds and creating growth opportunities through its network of multinational partnerships.
OurCrowd portfolio companies have achieved more than 50 exits. It has received more than $1.9B in committed funds for its 300+ portfolio companies and venture funds.
Visit us at: www.ourcrowd.com
- Industry Investment Management
- Website https://www.ourcrowd.com/
- LinkedIn https://www.linkedin.com/company/ourcrowd-llc/
Related People
Dan BennettInvestor
Australia -
Greater Sydney Area
Founder, relationship builder, business developer and all round lover of technical detail, with a strong management and leadership ethos, supported by 20 years of experience. My true love is for venture investing, but I have led major M&A and corporate finance transactions.
Prove | $40,000,000 | (Oct 18, 2023)
Reality Defender | $15,000,000 | (Oct 18, 2023)
Yardstik | $12,000,000 | (Oct 18, 2023)
Nucleus RadioPharma | $56,000,000 | (Oct 18, 2023)
Society Brands | $25,000,000 | (Oct 18, 2023)
Nova Credit | $45,000,000 | (Oct 18, 2023)
Anonybit | $3,000,000 | (Oct 18, 2023)
Zelus Analytics | Undisclosed Amount | (Oct 18, 2023)
Scorability | $11,000,000 | (Oct 18, 2023)